# Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

> **NCT01054079** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 20 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate
- Recurrent Prostate Cancer

## Interventions

- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** questionnaire administration
- **DRUG:** cinacalcet hydrochloride

## Key facts

- **NCT ID:** NCT01054079
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01054079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01054079, "Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01054079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*